Skip to main content

Effective Opioid Analgesic Alternatives and Approaches to Pain Management

  • Chapter
  • First Online:
Treating Opioid Addiction

Part of the book series: Current Clinical Psychiatry ((CCPSY))

  • 1487 Accesses

Abstract

Chronic pain affects millions of people every year. The recent focus on the opioid epidemic has brought substantial attention to the potential risks associated with opioid overprescribing. However, individuals who receive opioids differ in the extent to which they experience physiological dependence on opioids, engage in opioid misuse, or report symptoms of an opioid use disorder. Irrespective of the levels of opioid-related problems, there is a pressing need to develop and improve treatments for chronic pain and provide patients with greater access to pain interventions already known to be effective. The present chapter includes a concise overview of the literature on chronic pain treatment, with an emphasis on some of the consequences of, and alternatives to, opioid use. Non-opioid treatments for pain are described in detail as well as the extent to which these are supported by research. The underlying assumption of this chapter is that the current emphasis on reducing opioids provides a window of opportunity to critically evaluate the benefits and potential consequences of different pain treatments. However, even as researchers look for improved treatments, it is essential to continue to provide effective treatment to those with chronic pain – avoiding involuntary or rapid tapering of patients already receiving opioids and ensuring that high-risk groups, such as those with established substance use disorders, have access to effective pain treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Murthy VH. Ending the opioid epidemic – a call to action. N Engl J Med. 2016;375(25):2413–5.

    Article  PubMed  Google Scholar 

  2. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15(9):618–27.

    Article  PubMed  Google Scholar 

  3. Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107–11.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Bohnert ASB, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA J Am Med Assoc. 2011;305(13):1315–21.

    Article  CAS  Google Scholar 

  5. Rudd RA, et al. Increases in Drug and Opioid Overdose Deaths - United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–82.

    Article  PubMed  Google Scholar 

  6. Vivolo-Kantor AM, et al. Vital signs: trends in emergency department visits for suspected opioid overdoses – United States, July 2016–September 2017. MMWR Morb Mortal Wkly Rep. 2018;67(9):279–85.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363(21):1981–5.

    Article  CAS  PubMed  Google Scholar 

  8. Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Mil Med. 2016;181(5):397–9.

    Article  Google Scholar 

  9. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl. 1986;3:S1–226.

    Google Scholar 

  10. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547–55.

    Article  PubMed  CAS  Google Scholar 

  11. Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states – maybe it is all in their head. Best Pract Res Clin Rheumatol. 2011;25(2):141–54.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13(8):715–24.

    Article  PubMed  Google Scholar 

  13. Rubin DI. Epidemiology and risk factors for spine pain. Neurol Clin. 2007;25(2):353–71.

    Article  PubMed  Google Scholar 

  14. Johannes CB, et al. The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain. 2010;11(11):1230–9.

    Article  PubMed  Google Scholar 

  15. Tsang A, et al. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain. 2008;9(10):883–91.

    Article  PubMed  Google Scholar 

  16. Shmagel A, Foley R, Ibrahim H. Epidemiology of chronic low back pain in US Adults: data from the 2009-2010 National Health and Nutrition Examination Survey. Arthritis Care Res. 2016;68(11):1688–94.

    Article  Google Scholar 

  17. Chou R, Shekelle P. Will this patient develop persistent disabling low back pain? JAMA J Am Med Assoc. 2010;303(13):1295–302.

    Article  CAS  Google Scholar 

  18. Ahmedani BK, et al. Policies and events affecting prescription opioid use for non-cancer pain among an insured patient population. Pain Physician. 2014;17(3):205–16.

    PubMed  PubMed Central  Google Scholar 

  19. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980;302(2):123.

    CAS  PubMed  Google Scholar 

  20. Portenoy RK, Foley KM. Chronic use of opioid analgesics in nonmalignant pain – report of 38 cases. Pain. 1986;25(2):171–86.

    Article  CAS  PubMed  Google Scholar 

  21. Chou R, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276–86.

    Article  PubMed  Google Scholar 

  22. Fishbain DA, et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008;9(4):444–59.

    Article  PubMed  Google Scholar 

  23. Edlund MJ, et al. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 2007;129(3):355–62.

    Article  PubMed  Google Scholar 

  24. Krebs EE, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial. JAMA. 2018;319(9):872–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Chou R, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.

    Article  PubMed  Google Scholar 

  27. Ling W, Mooney L, Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 2011;30(3):300–5.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Vowles KE, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain. 2015;156(4):569–76.

    Article  PubMed  Google Scholar 

  29. Boyd CJ, McCabe SE. Coming to terms with the nonmedical use of prescription medications. Subst Abuse Treat Prev Policy. 2008;3:22.

    Article  PubMed  PubMed Central  Google Scholar 

  30. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.

    Book  Google Scholar 

  31. Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9(5):358–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hauser W, et al. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs. 2012;26(4):297–307.

    Article  PubMed  Google Scholar 

  33. Kroenke K, Krebs EE, Bair MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. GenHospPsychiatry. 2009;31(3):206–19.

    Google Scholar 

  34. Krebs EE, et al. Treating the physical symptoms of depression with second-generation antidepressants: a systematic review and metaanalysis. Psychosomatics. 2008;49(3):191–8.

    Article  PubMed  Google Scholar 

  35. Lynch ME. Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci. 2001;26(1):30–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician. 2013;87(11):766–72.

    PubMed  Google Scholar 

  37. Tompkins DA, Hobelmann JG, Compton P. Providing chronic pain management in the “Fifth Vital Sign” era: historical and treatment perspectives on a modern-day medical dilemma. Drug Alcohol Depend. 2017;173(Suppl 1):S11–21.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Yarnitsky D, et al. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain. 2012;153(6):1193–8.

    Article  CAS  PubMed  Google Scholar 

  39. Schmidt-Wilcke T, et al. Resting state connectivity correlates with drug and placebo response in fibromyalgia patients. Neuroimage Clin. 2014;6:252–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Lynch ME, Watson CP. The pharmacotherapy of chronic pain: a review. Pain Res Manag. 2006;11(1):11–38.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Attal N, Bouhassira D. Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms? Pain. 2015;156(Suppl 1):S104–14.

    Article  PubMed  Google Scholar 

  42. Staiger TO, et al. Systematic review of antidepressants in the treatment of chronic low back pain. Spine. 2003;28(22):2540–5.

    Article  PubMed  Google Scholar 

  43. Jann MW, Slade JH. Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy. 2007;27(11):1571–87.

    Article  CAS  PubMed  Google Scholar 

  44. Riediger C, et al. Adverse effects of antidepressants for chronic pain: a systematic review and meta-analysis. Front Neurol. 2017;8:307.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Harris RE, et al. Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiology. 2013;119(6):1453–64.

    Article  CAS  PubMed  Google Scholar 

  46. Slavova S, et al. Prevalence of gabapentin in drug overdose postmortem toxicology testing results. Drug Alcohol Depend. 2018;186:80–5.

    Article  CAS  PubMed  Google Scholar 

  47. Gatchel RJ. Comorbidity of chronic pain and mental health disorders: the biopsychosocial perspective. Am Psychol. 2004;59(8):795–805.

    Article  PubMed  Google Scholar 

  48. Gatchel RJ, et al. Interdisciplinary chronic pain management: past, present, and future. Am Psychol. 2014;69(2):119–30.

    Article  PubMed  Google Scholar 

  49. Geisser ME, Roth RS, Williams DA. The allure of a cure. J Pain. 2006;7(11):797–9.

    Article  PubMed  Google Scholar 

  50. Bair MJ, et al. Depression and pain comorbidity – a literature review. Arch Intern Med. 2003;163(20):2433–45.

    Article  PubMed  Google Scholar 

  51. Fishbain DA, et al. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain. 1997;13(2):116–37.

    Article  CAS  PubMed  Google Scholar 

  52. Casey CY, et al. Transition from acute to chronic pain and disability: a model including cognitive, affective, and trauma factors. Pain. 2008;134(1–2):69–79.

    Article  Google Scholar 

  53. Brown GK. A causal analysis of chronic pain and depression. J Abnorm Psychol. 1990;99(2):127–37.

    Article  CAS  PubMed  Google Scholar 

  54. Gatzounis R, et al. Operant learning theory in pain and chronic pain rehabilitation. Curr Pain Headache Rep. 2012;16(2):117–26.

    Article  PubMed  Google Scholar 

  55. Lethem J, et al. Outline of a Fear-Avoidance Model of exaggerated pain perception--I. Behav Res Ther. 1983;21(4):401–8.

    Article  CAS  PubMed  Google Scholar 

  56. Williams AC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2012;11:CD007407.

    PubMed  Google Scholar 

  57. Pincus T, McCracken LM. Psychological factors and treatment opportunities in low back pain. Best Pract Res Clin Rheumatol. 2013;27(5):625–35.

    Article  PubMed  Google Scholar 

  58. Hayes SC, et al. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006;44(1):1–25.

    Article  PubMed  Google Scholar 

  59. Veehof MM, et al. Acceptance-based interventions for the treatment of chronic pain: a systematic review and meta-analysis. Pain. 2011;152(3):533–42.

    Article  PubMed  Google Scholar 

  60. Kabat-Zinn J. Mindfulness-based interventions in context: past, present, and future. Clin Psychol Sci Pract. 2003;10(2):144–56.

    Article  Google Scholar 

  61. Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry. 1982;4(1):33–47.

    Article  CAS  PubMed  Google Scholar 

  62. Rosenzweig S, et al. Mindfulness-based stress reduction for chronic pain conditions: variation in treatment outcomes and role of home meditation practice. J Psychosom Res. 2010;68(1):29–36.

    Article  PubMed  Google Scholar 

  63. Cherkin DC, et al. Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial. JAMA J Am Med Assoc. 2016;315(12):1240–9.

    Article  CAS  Google Scholar 

  64. Gratzer D, Khalid-Khan F. Internet-delivered cognitive behavioural therapy in the treatment of psychiatric illness. Can Med Assoc J. 2016;188(4):263–72.

    Article  Google Scholar 

  65. Brown M, et al. Effectiveness of web-delivered acceptance and commitment therapy in relation to mental health and well-being: a systematic review and meta-analysis. J Med Internet Res. 2016;18(8):e221.

    PubMed  PubMed Central  Google Scholar 

  66. Spijkerman MPJ, Pots WTM, Bohlmeijer ET. Effectiveness of online mindfulness-based interventions in improving mental health: a review and meta-analysis of randomised controlled trials. Clin Psychol Rev. 2016;45:102–14.

    Article  CAS  PubMed  Google Scholar 

  67. Carville SF, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67(4):536–41.

    Article  CAS  PubMed  Google Scholar 

  68. Klement A, et al. Principles of treatment, coordination of medical care and patient education in fibromyalgia syndrome and chronic widespread pain. Schmerz. 2008;22(3):283–94.

    Article  CAS  PubMed  Google Scholar 

  69. Hayden JA, et al. Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev. 2005;3:CD000335.

    Google Scholar 

  70. Busch AJ, Barber KA, Overend TJ, Peloso PMJ, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database of Syst Rev. 2007;(4):CD003786. https://doi.org/10.1002/14651858.CD003786.pub2.

  71. Valim V, et al. Aerobic fitness effects in fibromyalgia. J Rheumatol. 2003;30(5):1060–9.

    PubMed  Google Scholar 

  72. Hassett AL, Williams DA. Non-pharmacological treatment of chronic widespread musculoskeletal pain. Best Pract Res Clin Rheumatol. 2011;25(2):299–309.

    Article  PubMed  Google Scholar 

  73. Feine JS, Lund JP. An assessment of the efficacy of physical therapy and physical modalities for the control of chronic musculoskeletal pain. Pain. 1997;71(1):5–23.

    Article  CAS  PubMed  Google Scholar 

  74. Deyle GD, et al. Physical therapy treatment effectiveness for osteoarthritis of the knee: a randomized comparison of supervised clinical exercise and manual therapy procedures versus a home exercise program. Phys Ther. 2005;85(12):1301–17.

    PubMed  Google Scholar 

  75. Walker MJ, et al. The effectiveness of manual physical therapy and exercise for mechanical neck pain: a randomized clinical trial. Spine (Phila Pa 1976). 2008;33(22):2371–8.

    Article  Google Scholar 

  76. Murthy V, Sibbritt DW, Adams J. An integrative review of complementary and alternative medicine use for back pain: a focus on prevalence, reasons for use, influential factors, self-perceived effectiveness, and communication. Spine J. 2015;15(8):1870–83.

    Article  PubMed  Google Scholar 

  77. Kessler RC, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med. 2001;135(4):262–8.

    Article  CAS  PubMed  Google Scholar 

  78. Witt C, et al. Acupuncture in patients with osteoarthritis of the knee: a randomised trial. Lancet. 2005;366(9480):136–43.

    Article  CAS  PubMed  Google Scholar 

  79. Ilgen MA, et al. Characteristics of adults seeking medical marijuana certification. Drug Alcohol Depend. 2013;132(3):654–9.

    Article  PubMed  Google Scholar 

  80. Lin LA, et al. Comparing adults who use cannabis medically with those who use recreationally: results from a national sample. Addict Behav. 2016;61:99–103.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Whiting PF, Wolff RF, Deshpande S. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA J Am Med Assoc. 2015;313(24):2456–73.

    Article  CAS  PubMed  Google Scholar 

  82. Nugent SM, Kansagara D. The effects of cannabis among adults with chronic pain. Ann Intern Med. 2018;168(7):525.

    Article  PubMed  Google Scholar 

  83. Boehnke KF, Litinas E, Clauw DJ. Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J Pain. 2016;17(6):739–44.

    Article  PubMed  Google Scholar 

  84. Vigil JM, et al. Associations between medical cannabis and prescription opioid use in chronic pain patients: a preliminary cohort study. PLoS One. 2017;12(11):e0187795.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  85. Campbell G, et al. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Health. 2018;3(7):e341–50.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Albert Einstein College of Medicine, I. MEMO-Medical Marijuana and Opioids Study [cited 14 Jan 2019]. Available from: https://clinicaltrials.gov/ct2/show/NCT03268551.

  87. Degenhardt L, et al. The impact of cohort substance use upon likelihood of transitioning through stages of alcohol and cannabis use and use disorder: findings from the Australian National Survey on Mental Health and Wellbeing. Drug Alcohol Rev. 2018;37(4):546–56.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Ilgen MA, et al. The timing of onset of pain and substance use disorders. Am J Addict. 2010;19(5):409–15.

    Article  PubMed  Google Scholar 

  89. Potter JS, Prather K, Weiss RD. Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict. 2008;17(2):121–5.

    Article  PubMed  Google Scholar 

  90. Ilgen MA, et al. A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction. 2016;111(8):1385–93.

    Article  PubMed  Google Scholar 

  91. Rai A, et al. A review of adjunctive CNS medications used for the treatment of post-surgical pain. CNS Drugs. 2017;31(7):605–15.

    Article  CAS  PubMed  Google Scholar 

  92. Ajay Manhapra MD, Albert J, Arias MD, Jane C, Ballantyne MD. The conundrum of opioid tapering in long-term opioid therapy for chronic pain: a commentary. Subst Abus. 2018;39(2):152–61. https://doi.org/10.1080/08897077.2017.1381663.

    Article  PubMed  Google Scholar 

  93. Edlund MJ, et al. Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011. Pain. 2014;155(11):2337–43.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Lin LA, et al. Impact of the opioid safety initiative on opioid-related prescribing in veterans. Pain. 2017;158(5):833–9.

    Article  PubMed  Google Scholar 

  95. Darnall BD, et al. Patient-centered prescription opioid tapering in community outpatients with chronic pain. JAMA Intern Med. 2018;178(5):707–8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jenna Goesling .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Goesling, J., Ilgen, M. (2019). Effective Opioid Analgesic Alternatives and Approaches to Pain Management. In: Kelly, J., Wakeman, S. (eds) Treating Opioid Addiction. Current Clinical Psychiatry. Humana, Cham. https://doi.org/10.1007/978-3-030-16257-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-16257-3_12

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-16256-6

  • Online ISBN: 978-3-030-16257-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics